| |
Log-rank test
|
Cox
|
|---|
|
Covariates
|
n
|
Pvalue
|
Pvalue
|
HR
|
95% CI
|
|---|
|
Age (≥70/<70 y)
|
33/23
|
0.355
| | | |
|
Sex (male/female)
|
42/14
|
0.424
| | | |
|
HCV (present/absent)
|
34/22
|
0.58
| | | |
|
*Main trunk (present/absent)
|
16/40
|
0.612
| | | |
|
Extrahepatic spread (present/absent)
|
5/51
|
0.278
| | | |
|
Previous treatments (present/absent)
|
38/18
|
0.546
| | | |
|
AFP ≥ 100 (ng/dL)
|
28/28
|
0.073
| | | |
|
DCP ≥ 1000 (mAU/mL)
|
27
|
0.066
|
0.024
|
1
| |
|
<1000
|
29
| | |
0.508
|
0.282, 0.915
|
|
Sorafenib
|
28
|
0.002
|
0.007
|
1
| |
|
RT
|
28
| | |
0.434
|
0.235, 0.779
|
-
Abbreviations: HCV hepatitis C virus, AFP α-fetoprotein, DCP des-γ-carboxy prothrombin, RT radiotherapy, HR hazard ratio, CI confidence interval.
- *Portal invasion to the main trunk.
